Union européenne -
français -
EMA (European Medicines Agency)
edistride
astrazeneca ab - dapagliflozine propanediol monohydraté - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - les médicaments utilisés dans le diabète - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. en outre, à d'autres médicaments pour le traitement du diabète de type 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 et 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
Union européenne -
français -
EMA (European Medicines Agency)
forxiga
astrazeneca ab - dapagliflozine propanediol monohydraté - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - les médicaments utilisés dans le diabète - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. en outre, à d'autres médicaments pour le traitement du diabète de type 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 et 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
Canada -
français -
Health Canada
qtern comprimé
astrazeneca canada inc - saxagliptine (chlorhydrate de saxagliptine); dapagliflozine (propanediol de dapagliflozine monohydraté) - comprimé - 5mg; 5mg - saxagliptine (chlorhydrate de saxagliptine) 5mg; dapagliflozine (propanediol de dapagliflozine monohydraté) 5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
Canada -
français -
Health Canada
qtern comprimé
astrazeneca canada inc - saxagliptine (chlorhydrate de saxagliptine); dapagliflozine (propanediol de dapagliflozine monohydraté) - comprimé - 5mg; 10mg - saxagliptine (chlorhydrate de saxagliptine) 5mg; dapagliflozine (propanediol de dapagliflozine monohydraté) 10mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
Canada -
français -
Health Canada
gln-dapagliflozin comprimé
glenmark pharmaceuticals canada inc. - dapagliflozine - comprimé - 5mg - dapagliflozine 5mg
Canada -
français -
Health Canada
gln-dapagliflozin comprimé
glenmark pharmaceuticals canada inc. - dapagliflozine - comprimé - 10mg - dapagliflozine 10mg
Canada -
français -
Health Canada
taro-dapagliflozin comprimé
taro pharmaceuticals inc - dapagliflozine - comprimé - 5mg - dapagliflozine 5mg
Canada -
français -
Health Canada
taro-dapagliflozin comprimé
taro pharmaceuticals inc - dapagliflozine - comprimé - 10mg - dapagliflozine 10mg
Canada -
français -
Health Canada
nat-dapagliflozin comprimé
natco pharma (canada) inc - dapagliflozine - comprimé - 5mg - dapagliflozine 5mg
Canada -
français -
Health Canada
nat-dapagliflozin comprimé
natco pharma (canada) inc - dapagliflozine - comprimé - 10mg - dapagliflozine 10mg